Evaluation and Management of Low Serum Iron with Elevated Ferritin
Primary Diagnostic Interpretation
Low serum iron combined with elevated ferritin most commonly indicates anemia of chronic disease (functional iron deficiency) rather than absolute iron deficiency, and requires immediate measurement of transferrin saturation and C-reactive protein to distinguish between these entities. 1
Algorithmic Diagnostic Approach
Step 1: Calculate Transferrin Saturation and Measure Inflammatory Markers
Calculate transferrin saturation (TSAT = serum iron × 100 ÷ total iron-binding capacity) immediately, as this is the critical discriminator between functional and absolute iron deficiency when ferritin appears elevated. 1, 2
Measure C-reactive protein concurrently, because ferritin is an acute-phase reactant that becomes falsely elevated by inflammation, infection, malignancy, or liver disease. 1, 3
Step 2: Apply Diagnostic Thresholds Based on Clinical Context
In Apparently Healthy Individuals:
TSAT < 16–20% with ferritin > 100 μg/L → anemia of chronic disease (functional iron deficiency). 1, 2
TSAT < 16% with ferritin < 100 μg/L → absolute iron deficiency, even when ferritin appears "normal," because inflammation may have falsely elevated it. 1, 2
Ferritin > 150 μg/L makes absolute iron deficiency unlikely unless severe inflammation is present. 2
In Patients with Inflammatory Conditions (IBD, CHF, CKD):
Use a higher ferritin threshold: ferritin < 100 μg/L or TSAT < 20% confirms iron deficiency in these populations, because standard thresholds do not apply when hepcidin is elevated. 3
If ferritin is 100–300 μg/L, TSAT < 20% is required to confirm iron deficiency. 3
Step 3: Exclude Iron Overload Syndromes
If TSAT > 60% with elevated ferritin, suspect hereditary hemochromatosis or secondary iron overload and proceed to genetic testing (HFE mutation analysis) or liver MRI for iron quantification. 4, 5
TSAT > 60% combined with ferritin > 963 μg/L correctly identifies 95% of patients with severe hepatic iron overload (liver iron > 7 mg/g dry weight), warranting immediate specialist referral. 5
Step 4: Consider Rare Genetic Disorders
If TSAT is remarkably low (< 10%) with low-normal ferritin (20–50 μg/L) and the patient fails to respond to oral iron, suspect iron-refractory iron deficiency anemia (IRIDA) caused by TMPRSS6 mutations. 1, 2
Measure soluble transferrin receptor (sTfR), which is elevated in IRIDA despite normal-to-high ferritin and is not influenced by inflammation. 2
If ferritin is markedly elevated (> 500 μg/L) with high TSAT and microcytic anemia persists despite normal iron studies, perform bone marrow examination for ring sideroblasts to diagnose sideroblastic anemia. 2
Management Algorithm
For Anemia of Chronic Disease (TSAT < 20%, Ferritin > 100 μg/L):
Treat the underlying inflammatory condition first, as this is the primary driver of functional iron deficiency. 3
Consider intravenous iron (iron sucrose, ferric carboxymaltose, or iron gluconate) rather than oral iron, because hepcidin elevation blocks intestinal iron absorption and mobilization from stores. 1, 3
Monitor serum ferritin during IV therapy and keep it below 500 μg/L to avoid iatrogenic iron overload, especially in children and adolescents. 1
For Absolute Iron Deficiency (TSAT < 16%, Ferritin < 100 μg/L):
Initiate oral iron supplementation immediately (ferrous sulfate 325 mg once to three times daily) while pursuing diagnostic workup for the source of iron loss. 1
Expect hemoglobin to rise ≥ 10 g/L within 2 weeks; this response confirms iron deficiency even when baseline iron studies were equivocal. 1, 2
Continue iron supplementation for at least 3 months after hemoglobin normalization until ferritin exceeds 50 μg/L to replenish stores. 1
For Iron-Refractory Iron Deficiency Anemia (IRIDA):
Switch to intravenous iron (iron sucrose or iron gluconate), as oral iron is ineffective due to hepcidin overexpression from TMPRSS6 mutations. 1, 2
Expect only partial correction of anemia; complete normalization is rarely achieved even with repeated IV iron infusions. 1
For Sideroblastic Anemia:
Trial pyridoxine (vitamin B6) 50–200 mg daily initially, then continue lifelong at 10–100 mg daily if responsive (applies to X-linked sideroblastic anemia from ALAS2 defects). 1, 2
For non-responsive cases, consider hematopoietic stem cell transplantation as the only curative option, with symptomatic management including transfusions and chelation therapy. 1, 2
Mandatory Investigation for Underlying Cause
When to Pursue Gastrointestinal Evaluation:
Adult men with hemoglobin < 110 g/L or non-menstruating women with hemoglobin < 100 g/L warrant fast-track bidirectional endoscopy (upper endoscopy with duodenal biopsies plus colonoscopy) to exclude gastrointestinal malignancy. 1, 2
Upper endoscopy with duodenal biopsies screens for celiac disease (present in 2–5% of iron-deficiency cases), gastric cancer, peptic ulcer disease, and NSAID-induced gastropathy. 1, 2
Colonoscopy detects colonic carcinoma, adenomatous polyps, angiodysplasia, and inflammatory bowel disease as potential bleeding sources. 1, 2
Do not delay investigation pending response to iron therapy, as this may miss gastrointestinal malignancy. 1
Additional Screening:
Assess dietary iron intake, particularly in vegetarians or those with restrictive eating patterns. 1
Document NSAID/aspirin use and discontinue if possible, as these are common causes of occult GI blood loss. 1
Screen for celiac disease serologically before endoscopy, as it accounts for 3–5% of iron-deficiency anemia cases. 1, 2
Critical Pitfalls to Avoid
Do not rely on ferritin alone when inflammation is present; always add TSAT to identify functional iron deficiency. 1, 2, 3
Do not assume all microcytic anemia is iron deficiency; anemia of chronic disease, thalassemia, and sideroblastic anemia require distinct management. 1, 2
Do not attribute iron deficiency solely to dietary insufficiency without excluding pathologic causes, especially in men and postmenopausal women. 1
Do not overlook combined micronutrient deficiencies; iron deficiency may coexist with vitamin B12 or folate deficiency, suggested by an elevated red-cell distribution width. 1, 2
Do not accept a single upper GI lesion (e.g., peptic ulcer) as the sole cause without completing lower GI evaluation, because dual pathology occurs in approximately 10–15% of cases. 2